INCMGA00012 Plus Chemotherapy in Participants With Advanced Solid Tumors (POD1UM-105)
Conditions: Advanced and/or Metastatic Solid Tumors; Stage IIIB Not Amenable to Curative Therapy to Stage IV Non-small Cell Lung Cancer; Advanced/Metastatic Unresectable Malignant Pleural Mesothelioma Interventions: Drug: INCMGA00012; Drug: Gemcitabine; Drug: Cisplatin; Drug: Pemetrexed; Drug: Carboplatin; Drug: Paclitaxel Sponsor: Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Alimta | Asbestosis | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Mesothelioma | Non-Small Cell Lung Cancer | Research